GLPwatch
Trials (2101)
Page 21 of 36.
- Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP)
- Comparison of Lixisenatide Injected Prior to the Main Meal of the Day Versus Prior to Breakfast in Type 2 Diabetic Patients on Metformin
- Biomarkers in Obese Patients With Knee Osteoarthritis; Weight Maintenance
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy
- Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in India
- A Trial Investigating the Effect of Probenecid and Ciclosporin on the Concentrations of SNAC in Healthy Subjects
- A Study of LY3841136 in Overweight and Obese Participants
- Changes in Skin Autoflouresence Following Weight Loss and Maintenance Using Liraglutide in Knee Osteoarthritis
- A Trial Investigating the Effect of Oral Semaglutide on the Pharmacokinetics of Furosemide and Rosuvastatin in Healthy Subjects
- Dapagliflozin As Additional Treatment To Liraglutide And Insulin In Patients With Type 1 Diabetes
- A Study of LY3537021 in Healthy Participants
- A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.
- Comparative Effectiveness of Tirzepatide Versus Sitagliptin in Individuals at Cardiovascular Risk (TIRZSITA-CVOT)
- Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
- Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
- Semaglutide for Smoking Cessation in Patients With Diabetes
- A Ph2 Study to Evaluate the Safety, Efficacy and Tolerability of HT-6184 and Semaglutide in Obese Participants With T2DM
- Tirzepatide in MetALD
- Tirzepatide in PWS, HO and GNSO
- Reversal to Normoglycemia by Treating Prediabetes
- Effect of Semaglutide and Tirzepatide Combined With Exercise in Obesity
- GLP1-imaging Before and After Bariatric Surgery
- Use of a GLP-1R Agonist to Treat Opioid Use Disorder
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight
- Effect Of Exenatide Treatment on Liver Fat Content in Patients With Diabetes
- Efficacy and Safety of Apitegromab for the Treatment of Adults Who Are Overweight or Obese
- Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss
- An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects
- The Effect of Dulaglutide as an Adjuvant Therapy on Cognitive Function in Bipolar Disorder Patients With Obesity
- A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants
- A Research Study to See How Well New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Levels in People With Type 2 Diabetes (T2D), Compared to Daily Insulin Glargine (COMBINE 4)
- Safety and Efficacy Study of Metaglidasen in Type 2 Diabetes in Patients Suboptimally Controlled on Insulin
- Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes
- Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Diet and Exercise Only
- Efficacy of Semaglutide s.c. Once-weekly on Weight Loss and Management in Adolescents With Monogenic Obesity in Clinical Practice
- A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
- A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide
- Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy
- Tirzepatide in the Treatment of Endometrial Cancer
- The Impact of Food on Blood Sugar in People With Type 2 Diabetes
- GLP-1 on Non-ST-Segment Elevation Myocardial Infarction
- A Study to (1) Compare How BI 456906 is Taken up in the Body of Healthy People and People With Liver Problems and (2) Find Out How People With Overweight and Obesity, With and Without Liver Problems, Tolerate Different Doses of BI 456906
- Impact of Discontinuing GLP-1 Receptor Agonists for Two Weeks Prior to Upper Endoscopy on the Risk of Gastric Retention
- Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes
- The Semaglutide Study
- Prevent and Reverse Obesity in Children, Adolescents and Young Adults
- An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes
- GLP-1 Receptor Targeting in Diabetic and Healthy Individuals
- Glucagon-like Peptide 1 Agonist Exenatide for Improved Glucose Control and Cardiac Function in Patients With Aortocoronary Bypass
- Extension of ALT-801 in Diabetic and Non-Diabetic Overweight and Obese Subjects With (NAFLD)
- How Glargine Insulin, Oral Diabetes Medications and Exenatide May Improve Blood Sugar Control and Weight Gain in Type 2 Diabetics
- The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure
- Liraglutide and a Calorie Restricted Diet Augments Weight Loss and Decreases Risk of Type 2 Diabetes and CVD.
- Epidemiological Assessment of the Risk for Pancreatic Cancer Associated With the Use of Semaglutide in Patients With Type 2 Diabetes - A Cohort Study Based on Nordic Registry Data
- Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
- A Research Study Looking at How a Single Dose of the Medicine Cagrilintide Works in Participants With Reduced Liver Function and in Healthy Participants With Normal Liver Function and How Cagrilintide is Absorbed and Used by the Body
- A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting
- The Effect of Semaglutide on Disordered Eating Behaviour in Type 2 Diabetic Patients
- Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM
- 24-week Study Comparing Lixisenatide to Sitagliptin as add-on to Metformin in Obese Type 2 Diabetic Patients Younger Than 50 Years